1 | KIM S H, KIM I, KOH Y, et al. The importance of physical function in patients with multiple myeloma for improving quality of life[J]. Support Care Cancer, 2020, 28(5): 2361-2367. |
2 | OKAMOTO S,URESHINO H, KIDOGUCHI K,et al.Clinical impact of the CONUT score in patients with multiple myeloma[J]. Ann Hematol, 2020, 99(1): 113-119. |
3 | LIU J F, DENG W W, CHEN L, et al. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer[J]. Mol Carcinog, 2018, 57(3): 429-439. |
4 | LI H R, LU Y, PANG Y Y, et al. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway[J]. Biomedecine Pharmacother, 2017, 86: 324-333. |
5 | 麦梓欣, 于天启, 范婷婷. 白术内酯Ⅰ能诱导U266细胞凋亡和增强硼替佐米的作用[J]. 中国实验血液学杂志, 2020, 28(1): 177-184. |
6 | RZESKI W, STEPULAK A, SZYMA?SKI M, et al. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells[J]. Naunyn Schmiedebergs Arch Pharmacol, 2006, 374(1): 11-20. |
7 | 任文娟. 白桦脂酸抑制大肠癌细胞增殖与迁移能力的研究[D]. 太原: 山西医科大学, 2010. |
8 | RAMSENTHALER C, GAO W, SIEGERT R J,et al. Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: a prospective, multi-centre longitudinal study[J]. Palliat Med, 2019, 33(5): 541-551. |
9 | MAATOUK I, HE S, BECKER N, et al. Association of resilience with health-related quality of life and depression in multiple myeloma and its precursors: results of a German cross-sectional study[J]. BMJ Open, 2018, 8(7): e021376. |
10 | UMIT E G, BAYSAL M, BAS V, et al. Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy[J]. J Oncol Pharm Pract, 2020, 26(1): 43-50. |
11 | LEE D, LEE S R, KANG K S, et al. Betulinic acid suppresses ovarian cancer cell proliferation through induction of apoptosis[J]. Biomolecules, 2019, 9(7): E257. |
12 | WANG S, WANG K X, ZHANG C D, et al. Overaccumulation of p53-mediated autophagy protects against betulinic acid-induced apoptotic cell death in colorectal cancer cells[J]. Cell Death Dis, 2017, 8(10): e3087. |
13 | TIWARI R, PUTHLI A, BALAKRISHNAN S, et al. Betulinic acid-induced cytotoxicity in human breast tumor cell lines MCF-7 and T47D and its modification by tocopherol[J]. Cancer Invest, 2014, 32(8): 402-408. |
14 | ZHAN X K, LI J L, ZHANG S, et al. Betulinic acid exerts potent antitumor effects on paclitaxel-resistant human lung carcinoma cells (H460) via G2/M phase cell cycle arrest and induction of mitochondrial apoptosis[J]. Oncol Lett, 2018, 16(3): 3628-3634. |
15 | LI N, GONG Z H, LI X J, et al. Betulinic acid inhibits the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis[J]. Int Immunopharmacol, 2019, 67: 186-193. |
16 | SHEN M, HU Y Q, YANG Y, et al. Betulinic acid induces ROS-dependent apoptosis and S-phase arrest by inhibiting the NF-κB pathway in human multiple myeloma[J]. Oxid Med Cell Longev, 2019, 2019: 5083158. |
17 | CHEN S J, BAI Y, LI Z, et al. A betulinic acid derivative SH479 inhibits collagen-induced arthritis by modulating T cell differentiation and cytokine balance[J]. Biochem Pharmacol, 2017, 126: 69-78. |
18 | LIU K K, WU Z Y, CHU J H, et al. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway[J]. Biomedecine Pharmacother, 2019, 115: 108913. |
19 | AL-JAMAL H A, JUSOH S A, YONG A C, et al. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells[J]. Asian Pac J Cancer Prev, 2014, 15(11): 4555-4561. |
20 | ZHAO S D, GUO J, ZHAO Y S, et al. Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling[J]. Am J Transl Res, 2016, 8(7): 3169-3178. |
21 | WANG S W, HU J, GUO Q H, et al. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway[J]. Oncol Rep, 2014, 32(5): 1991-1998. |
22 | LI M H, ZHENG W P, WANG C. CyclinD1 promotes lymph node metastasis by inducing lymphangiogenesis in human ovarian carcinoma[J]. Int J Clin Exp Pathol, 2018, 11(7): 3726-3731. |
23 | SADEGHI S, HOJATI Z, TABATABAEIAN H. Cooverexpression of EpCAM and c-myc genes in malignant breast tumours[J]. J Genet, 2017, 96(1): 109-118. |
24 | K?NIG S M, RISSLER V, TERKELSEN T, et al. Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level[J]. PLoS Comput Biol, 2019, 15(12): e1007485. |
25 | GANBARJEDDI S, AZIMI A, ZADI HEYDARABAD M, et al. Apoptosis induced by prednisolone occurs without altering the promoter methylation of BAX and BCL-2 genes in acute lymphoblastic leukemia cells CCRF-CEM[J]. Asian Pac J Cancer Prev, 2020, 21(2): 523-529. |